⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1760694 | 0.72 | — | — | |
| SCHEMBL22616854 | 0.72 | — | — | |
| SCHEMBL2999269 | 0.69 | — | — | |
| SCHEMBL31258171 | 0.69 | — | — | |
| SCHEMBL23245339 | 0.69 | — | — | |
| SCHEMBL1016480 | 0.69 | — | — | |
| SCHEMBL1019656 | 0.69 | — | — | |
| SCHEMBL312115 | 0.67 | — | — | |
| SCHEMBL9021825 | 0.67 | — | — | |
| SCHEMBL8082811 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116143757-B | Multifunctional compound, composition and application of degradable BTK kinase | 杭州和正医药有限公司 | 2024-07-05 | — | — | CN | disclosed |
| EP-4393907-A1 | POTASSIUM CHANNEL MODULATOR, COMPOSITION AND APPLICATION | Neushen Therapeutics (Shanghai) Co., Ltd (CN) | 2024-07-03 | — | — | EP | disclosed |
| EP-4342892-A1 | BRUTON'S TYROSINE KINASE AND MUTANT DEGRADER, COMPOSITION AND APPLICATION THEREOF | Hangzhou Healzen Therapeutics Co., Ltd. (CN) | 2024-03-27 | — | — | EP | disclosed |
| WO-2023104043-A1 | ANTI-APOPTOTIC PROTEIN BCL-2 INHIBITOR, PHARMACEUTICAL COMPOSITION AND USES THEREOF | 杭州和正医药有限公司 | 2023-06-15 | — | — | WO | disclosed |
| CN-116217566-A | Anti-apoptosis protein BCL-2 inhibitor, pharmaceutical composition and application thereof | 杭州和正医药有限公司 | 2023-06-06 | — | — | CN | disclosed |
| WO-2023088477-A1 | MULTIFUNCTIONAL COMPOUND CAPABLE OF DEGRADING BTK KINASE, AND COMPOSITION AND USE | 杭州和正医药有限公司 | 2023-05-25 | — | — | WO | disclosed |
| CN-116143757-A | Multifunctional compound, composition and application of degradable BTK kinase | 杭州和正医药有限公司 | 2023-05-23 | — | — | CN | disclosed |
| WO-2023274390-A1 | BRUTON'S TYROSINE KINASE AND MUTANT DEGRADER, COMPOSITION AND APPLICATION THEREOF | 杭州和正医药有限公司 | 2023-01-05 | — | — | WO | disclosed |
| CN-115557933-A | Bruton tyrosine kinase and mutant degradation agent, composition and application thereof | 杭州和正医药有限公司 | 2023-01-03 | — | — | CN | disclosed |
| CN-107074757-B | The manufacturing method of trifluoromethyl alkylthio chemical combination object | 组合化学工业株式会社 | 2019-05-03 | — | — | CN | disclosed |
| US-20060211577-A1 | Benzenesulphonamide derivatives as herbicides or desiccant/defoliant compounds | BASF AKTIENGESELLSCHAFT (DE) | 2006-09-21 | — | — | US | disclosed |
| CN-1649498-A | 3-heteroaryl substituted 5-methyloxymethyl isoxazolines used as herbicides | BASF AG (DE) | 2005-08-03 | — | — | CN | disclosed |
| US-20050165020-A1 | 3-heteroaryl substituted 5-methyloxymethyl isoxazolines used as herbicides | BASF AKTIENGESELLSCHAFT (DE) | 2005-07-28 | — | — | US | disclosed |
| CN-1084190-C | Dermatologic preparation composition containing prostacyclin as active ingredient | TEIJIN LTD (JP) | 2002-05-08 | — | — | CN | disclosed |
| US-5965611-A | TREATING CHRONIC PERIPHERAL ARTERIAL OCCLUSION BY ADMINISTERING EMULSION COMPRISING ISOCARBACYCLIN, VEGETABLE OIL, PHOSPHOLIPID, AND WATER | TEIGIN LIMITED (JP) | 1999-10-12 | — | — | US | disclosed |
| EP-0634171-B1 | PHARMACEUTICAL COMPOSITION FOR TREATING CEREBRAL THROMBOSIS | TEIJIN LTD (JP) | 1999-05-06 | — | — | EP | disclosed |
| EP-0761225-A1 | PHARMACEUTICAL COMPOSITION FOR TREATING PERIPHERAL CIRCULATION DISORDER | TEIJIN LIMITED (JP) | 1997-03-12 | — | — | EP | disclosed |
| US-5610182-A | ADMINISTERING AN ISOCARBACYCLIN OF SPECIFIC STRUCTURE IN THE FORM OF A FAT EMULSION | TEIJIN, LIMITED (JP) | 1997-03-11 | — | — | US | disclosed |
| CN-1102038-A | External skin therapeutic agent composition containing prostacyclin as active ingredient | TEIJIN LTD (JP) | 1995-04-26 | — | — | CN | disclosed |
| EP-0634171-A1 | PHARMACEUTICAL COMPOSITION FOR TREATING CEREBRAL THROMBOSIS | TEIJIN LIMITED (JP) | 1995-01-18 | — | — | EP | disclosed |